Société Médicale BALOMENOU MARINAKIS
0507.612.183 · rovalta.com · 27/09/2026
Société Médicale BALOMENOU MARINAKIS
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOSociété Médicale BALOMENOU MARINAKIS is a Private limited company incorporated in 2014. Its registered office is in Montigny-le-Tilleul.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0507.612.183
- Incorporation
- 19/12/2014
- Legal form
- Private limited company
- Registered office
- Rue Chevelot 5
6110 Montigny-le-Tilleul · WallonieSee on map - Contributed capital
- 8 660,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 280,2 k € | +1.3% | 276,6 k € | +53.8% | 179,8 k € | -18.4% | 220,3 k € | +69.8% | 129,8 k € |
| EBITDA | 279,8 k € | +1.3% | 276,2 k € | +53.9% | 179,4 k € | -18.4% | 220 k € | +70.0% | 129,4 k € |
| Operating result | 264,5 k € | +1.4% | 260,9 k € | +50.8% | 173,1 k € | -20.7% | 218,1 k € | +71.0% | 127,6 k € |
| Net result | 78,9 k € | -23.9% | 103,8 k € | +2.3% | 101,5 k € | +52.8% | 66,4 k € | +472% | 11,6 k € |
| Balance sheet | |||||||||
| Equity | 296,9 k € | +0.8% | 294,5 k € | +30.0% | 226,5 k € | +15.0% | 197 k € | +36.7% | 144,1 k € |
| Total assets | 376,6 k € | +12.6% | 334,6 k € | +4.4% | 320,3 k € | +37.6% | 232,8 k € | +58.1% | 147,2 k € |
| Cash | 220,2 k € | +34.0% | 164,3 k € | +23.5% | 133 k € | +23.2% | 108 k € | +254% | 30,5 k € |
| Debts | 79,8 k € | +99.1% | 40,1 k € | -57.3% | 93,8 k € | +162% | 35,8 k € | +1041% | 3,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 2 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
SOTIRIOS MARINAKIS | Manager | since 19/12/2014 |
SPYRIDOULA BALOMENOU | Manager | since 19/12/2014 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
SOTIRIOS MARINAKIS | Manager | 19/12/2014 → 19/12/2020 |
Spyridoula BALOMENOU | Manager | 19/12/2014 → 19/12/2020 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 27/08/2025 | 22/08/2024 | 15/08/2023 | 12/08/2022 | 02/08/2021 |
| General meeting | 12/06/2026 | 27/06/2025 | 28/06/2024 | 30/06/2023 | 24/06/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 12/06/2026 | 31/08/2026 | French | |
| Micro model | 31/12/2024 | 27/06/2025 | 27/08/2025 | French | |
| Micro model | 31/12/2023 | 28/06/2024 | 22/08/2024 | French | |
| Micro model | 31/12/2022 | 30/06/2023 | 15/08/2023 | French | |
| Micro model | 31/12/2021 | 24/06/2022 | 12/08/2022 | French | |
| Micro model | 31/12/2020 | 25/06/2021 | 02/08/2021 | French | |
| Micro model | 31/12/2019 | 26/06/2020 | 29/09/2020 | French | |
| Micro model | 31/12/2018 | 28/06/2019 | 31/07/2019 | French | |
| Micro model | 31/12/2017 | 29/06/2018 | 26/07/2018 | French | |
| Micro model | 31/12/2016 | 30/06/2017 | 26/08/2017 | French | |
| Abridged model | 31/12/2015 | 24/06/2016 | 17/08/2016 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 2 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
SOTIRIOS MARINAKIS | Manager | since 19/12/2014 |
SPYRIDOULA BALOMENOU | Manager | since 19/12/2014 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
SOTIRIOS MARINAKIS | Manager | 19/12/2014 → 19/12/2020 |
Spyridoula BALOMENOU | Manager | 19/12/2014 → 19/12/2020 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202578,9 k €↓
- 2024Annual accounts 2024103,8 k €↑
- 2023Annual accounts 2023101,5 k €↑
- 2022Annual accounts 202266,4 k €↑
- 2021Annual accounts 202111,6 k €↑
- 2020Annual accounts 2020-3 k €↓
- 2019Annual accounts 201935,8 k €↓
- 2018Annual accounts 201877,4 k €↑
- 2017Annual accounts 201714 k €↑
- 2016Annual accounts 201610,4 k €↑
- 2015Annual accounts 2015-8,8 k €
- 19/12/2014IncorporationPrivate limited company
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Société Médicale BALOMENOU MARINAKISCurrent | CBE, tracked since 27/09/2026 | CBE |
| SBM MEDICALE | accounts 2021 → 2025 | Accounts 2025 · 2026-00473341 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.